Grund named to head Merck Korea

Published: 2013-07-17 06:57:00

Updated: 2013-07-17 06:57:00

Merck Korea, the local affiliate of the German chemical and pharmaceutical giant, said Monday it has appointed as its chief executive officer, Michael Grund.

Grund, who has a degree in chemical engineering from the Technical University of Dortmund in Germany, joined Merck in 1997.

Before ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK